Skip to content

Docudrama for Blood Donation in Ghana (DDID)

Using a Docudrama Intervention to Increase Repeat Donation Among First-time Blood Donors in Ghana: a Pilot Cluster Randomized, Pragmatic Type 1 Effectiveness- Implementation Hybrid Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07093307
Acronym
DDID
Enrollment
180
Registered
2025-07-30
Start date
2025-08-11
Completion date
2026-08-31
Last updated
2025-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Donation

Keywords

Docudrama

Brief summary

A cluster pilot RCT to evaluate the effectiveness of the docudrama compared to a control group (usual engagement with blood services) on repeat blood donation attempts among first-time blood donors. Secondary outcomes will be blood donor retention, attitudes, subjective norms, perceived behavioral control and intention as potential mediators of blood donation behavior among first-time blood donors. The cluster pilot RCT will have two arms: 1) docudrama and 2) control. Randomization will stratify by the type of site: mobile versus fixed. Each participant in the docudrama arm will receive the intervention one time immediately after blood donation. Participants in both the docudrama arm and control arm will receive standard blood donor communications and will be followed for six months. Actualized blood donation is possible every four months using NBSG guidelines; however, blood donation sessions may not occur at the blood donation sites until six months. Return blood donation attempts will be evaluated using the Southern Zonal Blood Center (SZBC) records (primary outcome) and participant self-report (secondary outcome) at six months. Secondary measures will be evaluated at baseline and six months from enrollment. The duration of the study will be 11 months, allowing for five months to achieve enrollment goals and six months of follow-up for the last individual enrolled.

Interventions

BEHAVIORALDocudrama

Participants at docudrama sites will watch a 30-minute docudrama (two episodes of 15 minutes each) immediately after blood donation while waiting to recover and to be refreshed.

BEHAVIORALControl

Participants randomized at control sites will receive the standard NBSG communications for blood donors: 1) a thank you phone call and 2) and a reminder phone call two-weeks prior to when they are due for their next blood donation.

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Syracuse University
CollaboratorOTHER
National Blood Service Ghana
CollaboratorOTHER
University of Ghana
CollaboratorOTHER
University of Minnesota
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Intervention model description

Cluster randomized

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* At least 18 years-old * First-time whole blood donor with the SZBC of the NBSG * Eligible to donate again at the time of eligibility confirmation * Consent to participate * Has a valid contact phone number or access to a valid contact phone number * Understands one of English, Twi, or Ga * Be willing to watch a docudrama on blood donation

Exclusion criteria

* History of more than one lifetime whole blood donation (with any blood center)

Design outcomes

Primary

MeasureTime frameDescription
Proportion of participants with a verified repeat blood donation attemptWithin 6 months after randomizationSelf-report of a blood donation attempt at the 6 month follow-up phone call using a questionnaire that is administered by study research staff over the phone. Self-reported attempts are then verified using the National Blood Services Ghana (NBSG) national blood donation database.

Countries

Ghana

Contacts

Primary ContactSusan E Telke, MS
telke001@umn.edu+1 612-590-2697

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026